Allogeneic HSCT increased risk for oral, esophageal cancers Healio Allogeneic hematopoietic stem cell transplantation doubled the risk for secondary solid cancers and further increased the risk for oral and esophageal cancers, according to study results. The increased risk for developing solid tumors after allogeneic ... |
